Literature DB >> 3691536

Increased efficiency of translation of ornithine decarboxylase mRNA in mitogen-activated lymphocytes.

M W White1, T Kameji, A E Pegg, D R Morris.   

Abstract

Ornithine decarboxylase (ODC) mRNA was elevated ninefold by 6 h following concanavalin A (ConA) stimulation of bovine lymphocytes. Comparison of the increases in ODC mRNA and ODC activity revealed a fivefold discrepancy, which is consistent with a change in efficiency of translation of ODC mRNA. In resting cells, 45% of the total ODC mRNA was associated with particles sedimenting at about 40 S, and therefore was not translated. The untranslated ODC mRNA in resting cells could be completely shifted into polysomes by a 15-min treatment of the cells with appropriate concentrations of cycloheximide. In activated cells, the proportion of ODC mRNA in untranslated material was reduced to 18%. This shift in distribution of ODC mRNA occurred between 6 h and 12 h following mitogen stimulation with no increase in the cellular level of this message. The rate of synthesis of ODC protein was found in increase twofold between 6 h and 12 h, paralleling the increase in the amount of ODC mRNA associated with polysomes. Thus, in this time frame, a decrease in the amount of untranslated ODC mRNA with a corresponding increase in the amount associated with polysomes leads to an increase in the biosynthesis of ODC with no change in the cellular level of the message. These changes in translational efficiency were not observed with actin mRNA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691536     DOI: 10.1111/j.1432-1033.1987.tb13670.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

1.  Immunosuppressants FK506 and rapamycin have different effects on the biosynthesis of cytoplasmic actin during the early period of T cell activation.

Authors:  S Miyamoto; B Safer
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

Review 2.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

3.  Multiple promoter elements govern expression of the human ornithine decarboxylase gene in colon carcinoma cells.

Authors:  J A Moshier; D L Osborne; M Skunca; J Dosescu; J D Gilbert; M C Fitzgerald; G Polidori; R L Wagner; S J Friezner Degen; G D Luk
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

4.  Specific regulation by endogenous polyamines of translational initiation of S-adenosylmethionine decarboxylase mRNA in Swiss 3T3 fibroblasts.

Authors:  M W White; C Degnin; J Hill; D R Morris
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

5.  Importance of the 3' untranslated region of ornithine decarboxylase mRNA in the translational regulation of the enzyme.

Authors:  E Lövkvist Wallström; K Takao; A Wendt; C Vargiu; H Yin; L Persson
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

Review 6.  Polyamine--DNA nexus: structural ramifications and biological implications.

Authors:  D Balasundaram; A K Tyagi
Journal:  Mol Cell Biochem       Date:  1991-02-02       Impact factor: 3.396

7.  Polyamine-mediated regulation of mouse ornithine decarboxylase is posttranslational.

Authors:  T van Daalen Wetters; M Macrae; M Brabant; A Sittler; P Coffino
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

8.  Multiple active conformers of mouse ornithine decarboxylase.

Authors:  S E Tsirka; C W Turck; P Coffino
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

9.  Domains within the mammalian ornithine decarboxylase messenger RNA have evolved independently and episodically.

Authors:  G J Johannes; F G Berger
Journal:  J Mol Evol       Date:  1993-06       Impact factor: 2.395

10.  A nucleolar AAA-NTPase is required for parasite division.

Authors:  Elena S Suvorova; Joshua B Radke; Li-Min Ting; Sumiti Vinayak; Carmelo A Alvarez; Stella Kratzer; Kami Kim; Boris Striepen; Michael W White
Journal:  Mol Microbiol       Date:  2013-09-11       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.